- Home
- Featured Publications
- Center Publications
- Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.
Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.
Citation | “Baseline Psychosocial Characteristics Predict Frequency Of Continuous Glucose Monitoring In Youth With Type 1 Diabetes.”. Diabetes Technology & Therapeutics, pp. 434-439. . |
Center | Joslin Diabetes Center |
Author | Dayna E McGill, Lisa K Volkening, Deborah A Butler, Kara R Harrington, Michelle L Katz, Lori M Laffel |
Keywords | Continuous glucose monitoring, Depressive symptoms, Diabetes burden, Quality of life, Technology, Youth |
Abstract |
BACKGROUND: Consistent use of continuous glucose monitoring (CGM) has been associated with improved glycemic control in youth with type 1 diabetes (T1D). There are many barriers to device uptake and continued use. There is a need to understand patient-specific characteristics when considering CGM. We evaluated patterns of CGM use and associations between baseline psychosocial measures and frequency of CGM use over 1 year. METHODS: Youth with T1D (n = 120), ages 8-18 years, completed questionnaires at CGM initiation and after 6 and 12 months assessing depressive symptoms, diabetes burden, and diabetes-specific and generic quality of life (QOL). RESULTS: Youth (51% male and 95% white) had mean age 12.7 ± 2.7 years, diabetes duration 6.1 ± 3.6 years, and glycated hemoglobin (HbA) 8.0 ± 0.8%. Over 1 year, 35% of youth used CGM 6 to 7 days per week, 45% used CGM 3-5 days per week, and 20% used CGM only 0-2 days per week. Youth who used CGM 3-7 days per week over 12 months had lower HbA at months 9 and 12 than youth who used CGM 0-2 days per week (9 months: 7.9 ± 0.9% vs. 8.5 ± 1.1%, P = 0.006 and 12 months: 8.0 ± 0.9% vs. 8.5 ± 1.1%, P = 0.02). Those using CGM 0-2 days per week had greater endorsement of depressive symptoms and diabetes burden and reported lower QOL at baseline compared with those using CGM 3-7 days per week. CONCLUSIONS: CGM use for 3 or more days per week over 12 months had a protective effect on HbA. Providers should consider addressing psychosocial parameters when initiating CGM to maximize uptake and promote continued use in youth with T1D. |
Year of Publication |
2018
|
Journal |
Diabetes technology & therapeutics
|
Volume |
20
|
Issue |
6
|
Number of Pages |
434-439
|
Date Published |
12/2018
|
ISSN Number |
1557-8593
|
DOI |
10.1089/dia.2018.0037
|
Alternate Journal |
Diabetes Technol. Ther.
|
PMID |
29727245
|
PMCID |
PMC6014048
|
Download citation |